Scynexis (Cyclophilin Inhibitor Assets) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Scynexis (Cyclophilin Inhibitor Assets) General Information

Description

A portfolio of cyclophilin inhibitor assets, patents and patent applications.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Jersey City, NJ
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Cypralis
Corporate Office
  • Jersey City, NJ
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scynexis (Cyclophilin Inhibitor Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Scynexis (Cyclophilin Inhibitor Assets)‘s full profile, request access.

Request a free trial

Scynexis (Cyclophilin Inhibitor Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Scynexis (Cyclophilin Inhibitor Assets)‘s full profile, request access.

Request a free trial

Scynexis (Cyclophilin Inhibitor Assets) FAQs

  • Where is Scynexis (Cyclophilin Inhibitor Assets) headquartered?

    Scynexis (Cyclophilin Inhibitor Assets) is headquartered in Jersey City, NJ.

  • What industry is Scynexis (Cyclophilin Inhibitor Assets) in?

    Scynexis (Cyclophilin Inhibitor Assets)’s primary industry is Buildings and Property.

  • Is Scynexis (Cyclophilin Inhibitor Assets) a private or public company?

    Scynexis (Cyclophilin Inhibitor Assets) is a Private company.

  • What is Scynexis (Cyclophilin Inhibitor Assets)’s current revenue?

    The current revenue for Scynexis (Cyclophilin Inhibitor Assets) is .

  • Who are Scynexis (Cyclophilin Inhibitor Assets)’s investors?

    Scynexis has invested in Scynexis (Cyclophilin Inhibitor Assets).

  • When was Scynexis (Cyclophilin Inhibitor Assets) acquired?

    Scynexis (Cyclophilin Inhibitor Assets) was acquired on 13-Jul-2016.

  • Who acquired Scynexis (Cyclophilin Inhibitor Assets)?

    Scynexis (Cyclophilin Inhibitor Assets) was acquired by Cypralis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process